tiprankstipranks
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
US Market
NRXP
NRX Pharmaceuticals
RESEARCH TOOLSreports

NRX Pharmaceuticals (NRXP) Financial Statements

Compare
846 Followers

NRX Pharmaceuticals Financial Overview

NRX Pharmaceuticals's market cap is currently $72.42M. The company's EPS TTM is $-0.04; its P/E ratio is -2.03; NRX Pharmaceuticals is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is $0.31. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Mar 24Dec 22Mar 22
Income Statement
Total Revenue$ 1.23M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 577.00K$ -5.00K$ -5.00K$ -4.00K$ -2.00K
Operating Income$ -16.22M$ -19.70M$ -27.59M$ -44.34M$ -95.20M
EBITDA$ -16.04M$ -24.04M$ -30.02M$ -39.75M$ -93.04M
Net Income$ -28.62M$ -25.13M$ -30.15M$ -39.75M$ -93.06M
Balance Sheet
Cash & Short-Term Investments$ 7.80M$ 1.44M$ 4.59M$ 20.05M$ 27.61M
Total Assets$ 12.96M$ 3.65M$ 7.32M$ 25.82M$ 32.73M
Total Debt$ 631.00K$ 6.58M$ 9.16M$ 10.53M$ 518.00K
Net Debt$ -7.17M$ 5.13M$ 4.57M$ -9.53M$ -27.09M
Total Liabilities$ 28.89M$ 26.87M$ 19.05M$ 18.41M$ 11.92M
Stockholders' Equity$ -15.94M$ -23.22M$ -11.73M$ 7.41M$ 20.81M
Cash Flow
Free Cash Flow$ -14.11M$ -10.64M$ -21.66M$ -39.77M$ -37.71M
Operating Cash Flow$ -14.11M$ -10.64M$ -21.66M$ -39.76M$ -37.70M
Investing Cash Flow$ -2.81M$ 0.00$ -3.00K$ -10.00K$ -7.00K
Financing Cash Flow$ 23.28M$ 7.49M$ 6.20M$ 32.21M$ 63.46M
Currency in USD

NRX Pharmaceuticals Earnings and Revenue History

Income Statement >

NRX Pharmaceuticals Debt to Assets

Balance Sheet >

NRX Pharmaceuticals Cash Flow

Cash Flow >

NRX Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >